Tech News
clear
Topic Analysis: Today This Week This Month This Year
1.
After the FDA crackdown, here’s how some companies are still selling GLP-1s (feeds.feedburner.com)
2.
Novo Nordisk Abruptly Ends Partnership with Hims, Claiming ‘Sham Compounding’ GLP-1 Drugs (gizmodo.com)
3.
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage (cnbc.com)
4.
Shares of Hims & Hers tumble 23% after FDA says semaglutide is no longer in shortage (cnbc.com)
Today's top topics: beware beware enterprises clothes clothes henry clothes new social duffy isaacman nasa app store
View all today's topics →